Records containing: Ocular Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-05-13Randomized, Multicenter, Dbl-Masked, Parallel Study Evaluating the 24 Hr. Diurnal Ocular Hypotensive Effect of 2% Dorzolamide Hydrochloride/0.5% Timolol Maleate Combo. Ophthalmic Sol. in Patients w/ Open Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2015-05-06ClinicalTrials.gov study NCT01830140
-
CLINICAL_TRIALS study record update · 2015-04-27ClinicalTrials.gov study NCT01735214
-
CLINICAL_TRIALS study record update · 2015-04-24A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
-
CLINICAL_TRIALS study record update · 2015-04-23An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-04-21A 12 Week Comparison of DuoTrav and Xalacom at 24 Hours Post-Dose in the Treatment of Open-Angle Glaucoma (the DVX Study)
-
CLINICAL_TRIALS study record update · 2015-04-13Prospective, Randomized, Single-Center Study to Evaluate 24-hour Intraocular Pressure Control With Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination Therapy
-
CLINICAL_TRIALS study record update · 2015-04-02ClinicalTrials.gov study NCT02108288
-
CLINICAL_TRIALS study record update · 2015-03-19Ocular Hypertension Treatment Study (OHTS)
-
CLINICAL_TRIALS study record update · 2015-03-04ClinicalTrials.gov study NCT02379208
-
CLINICAL_TRIALS study record update · 2015-01-26ClinicalTrials.gov study NCT01863953
-
CLINICAL_TRIALS study record update · 2015-01-21A Phase 2a, Multicenter, Randomized, Double-masked, Placebo-controlled, Parallel-group Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2015-01-21A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Ascending Dose Study of INS115644 Ophthalmic Solution in Subjects With Bilateral Ocular Hypertension or Early Primary Open Angle Glaucoma
-
CLINICAL_TRIALS study record update · 2015-01-06ClinicalTrials.gov study NCT01467440
-
CLINICAL_TRIALS study record update · 2015-01-06ClinicalTrials.gov study NCT01467388
-
CLINICAL_TRIALS study record update · 2014-12-17A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2014-12-16Neurovascular Coupling in Eyes of Glaucoma Patients
-
CLINICAL_TRIALS study record update · 2014-12-11Safety and Efficacy to Reduce the IOP of the Fixed Association of Latanoprost 0.005% (50 μg/mL)/ Brinzolamide 1% (10mg/mL) Drops, Compared to Latanoprost 0.005% (50 μg/mL) Drops, in Patients With Open Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2014-10-28An Open-label, Phase IV, Pilot Study, to Evaluate Confocal Microscopic Findings of Cornea, Ocular Signs and Symptoms in Patients With OH or OAG Switching From Latanoprost 0.005% to Preservative Free Tafluprost 0.0015% Eye Drops
-
CLINICAL_TRIALS study record update · 2014-09-30A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
-
CLINICAL_TRIALS study record update · 2014-09-10ClinicalTrials.gov study NCT01241240
-
CLINICAL_TRIALS study record update · 2014-08-18A Study of the Effects of a Single Osteopathic Manipulative Treatment (OMT) on Intraocular Pressure (IOP)in Un-medicated Confirmed Ocular Hypertensive (OHT) or Glaucoma Suspect Subjects
-
CLINICAL_TRIALS study record update · 2014-08-15ClinicalTrials.gov study NCT01547598
-
CLINICAL_TRIALS study record update · 2014-08-05ClinicalTrials.gov study NCT01110499
-
CLINICAL_TRIALS study record update · 2014-07-31ClinicalTrials.gov study NCT01781962